⌘K

Login Start Free

Home/Filings/4/0001104659-20-133326

4//SEC Filing

Mann Brenda 4

Accession 0001104659-20-133326

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 8:17 PM ET

Size

4.7 KB

Accession

0001104659-20-133326

Insider Transaction Report

Form 4

Period: 2020-12-07

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2020-12-07$3.76/sh−91$342→ 17,371 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 12/01/2020.

Documents

1 file

4
tm2038041-4_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 8:17 PM ET
Size: 4.7 KB

View on SEC.gov